Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing levobupivacaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
levobupivacain 7,5 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
|
levobupivacain 5 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
|
levobupivacain 2,5 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
|
Levobupivacaine hydrochloride (substance) |
Is a |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
|
levobupivacain 1,25 mg/ml injektionsvæske, opløsning, pose a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
|
levobupivacain 0,625 mg/ml injektionsvæske, opløsning, pose a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
|
levobupivacain 1,25 mg/ml injektionsvæske, opløsning, pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
|
levobupivacain 0,625 mg/ml injektionsvæske, opløsning, pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
|
Levobupivacaine hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 25 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 50 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 75 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 62.5 milligram/100 milliliter conventional release solution for injection bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 125 milligram/200 milliliter conventional release solution for injection bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 125 milligram/100 milliliter conventional release solution for injection bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 250 milligram/200 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only levobupivacaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 1.25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 625 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 1.25 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 1.25 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 7.5 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 7.5 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 2.5 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 2.5 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 5 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 5 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levobupivacaine (substance) |
Inferred relationship |
Some |
1 |